Learn about clinical trials and research opportunities in Diagnosis/Treatment section
Learn about clinical trials and research opportunities in Diagnosis/Treatment section
CURE OM's 13th "Eyes on a Cure: Patient & Caregiver Symposium"
When: May 3–5, 2024
Where: Boston, Massachusetts (and Online)
CLICK ON AN OCULAR MELANOMA CONFERENCE BELOW TO SEE THE LIST OF PRESENTATIONS, NAMES OF PRESENTERS, AND VIDEO LINKS.
Links to conference presentations will be added here when the videos are posted by A Cure in Sight.
Medical Presentation:
• Uveal Melanoma: Where We Are and Where We Are Going (Dr. Marlana Orloff; 45 minutes)
Medical Presentations:
• Uniting the OM Community: Keeping Our Eyes on A Cure [Including Latest Information on VISION Patient Registry] (Dr. Sara Selig; 45 minutes)
• Development of the Ocular Oncology Clinical Nurse Consultant Role: Impact on Patient Care (Clinical Nurse Peta Holly; 10 minutes)
Medical Presentations:
• Determinants of PKC Inhibitor Response in Uveal Melanoma (Professor Helen Rizos; 15 minutes)
• Drug Discovery and Development in Human Uveal Melanoma (Associate Professor Fanfan Zhou; 15 minutes)
• Improving Plaque Brachytherapy for Uveal Melanoma (Honorary Researcher Jeremy Flanagan; 15 minutes)
• Q&A (All Video 3 Presenters; 5 minutes)
Medical Presentations:
• How Do Optometrists Manage Choroidal Melanocytic Lesions? (Associate Professor Michelle Madigan; 15 minutes)
• Uveal Melanoma Tumour Biopsy: South Australia Experience (Dr. David Sia; 10 minutes)
• Uveal Melanomas: South Australia Pathology Experience (Dr. Amardeep Gilhotra; 10 minutes)
• An Update on Proton Therapy in Australia and Clinical Application (Associate Professor Peter Gorayski; 20 minutes)
• The Incidence and Mortality of Conjunctival Melanoma in Australia (Dr. Aaron Beasley; 15 minutes)
• Q&A (All Video 4 Presenters; 10 minutes)
Medical Presentations:
• Locoregional Therapies for Metastatic Uveal Melanoma (Professor Roger Olofsson Bagge; 30 minutes)
• Genomics and Prognostication in Uveal Melanoma (Dr. Emine Kilic; 35 minutes)
• Q&A (All Video 5 Presenters; 15 minutes)
Medical Presentations:
• Primary Disease: Intra-Ocular Melanocytic Lesions (Dr. Ezekiel Weis; 40 minutes)
• Estimation of Metastatic Risk in Uveal Melanoma (Dr. Hatem Krema; 55 minutes)
• Genomic Testing for Uveal Melanoma (Castle Biosciences' Katherina Alsina, PhD, 15 minutes)
• Uveal Melanoma Prognostic Tumor Test (Impact Genetics' Jaime Jessen, Certified Genetic Counselor; 10 minutes)
Medical Presentations:
• Metastatic Uveal Melanoma (Dr. Marcus Butler; 45 minutes)
Presentations by patients are also included in each day's video.
All presentations are provided together in a 6-hour video by the conference hosts. The time stamp info below shows where you will find the specific presentation within the video.
Medical Presentations:
• Ocular Melanoma: Biology, Epidemiology, Diagnosis, and Local Treatment (Dr. Andrew Stacey; 9:40 time stamp; 50 minutes)
• Proton Therapy for Ocular Melanoma: Continued Innovation (Dr. Lia Halasz; 1:00:45 time stamp; 35 minutes)
• Systemic Therapy Options for Advanced Ocular Melanoma: Past, Present, and Future (Dr. Evan Hall; 1:38:15 time stamp; 40 minutes)
• Liver-Directed Therapies for Metastatic Ocular Melanoma (Dr. Wayne Monsky; 2:17:00 time stamp; 30 minutes)
• Predicting Metastasis in Uveal Melanoma: A Research Update (Dr. Alison Skalet; 2:46:30 time stamp; 65 minutes)
• Managing Fear of Recurrence (Dr. Julia Brechbiel; 4:31:30 time stamp; 25 minutes)
• Genetic Testing for Inherited Cancer Risks (Lauren Facchini, Genetic Counselor; 4:54:30 time stamp; 20 minutes)
Medical Presentations:
Primary Ocular Melanoma
• Ocular Melanoma Past, Present, and Future (Dr. William Harbour; 45 minutes)
• Primary Ocular Melanoma 101 (Dr. Basil Williams; 30 minutes)
• Prognostication and Ocular Care After Treatment of Uveal Melanoma (Dr. Zelia Correa; 30 minutes)
• Q&A About Primary Ocular Melanoma (Panel of Presenters; 10 minutes)
Metastatic Ocular Melanoma
• Liver-Directed Therapies for Metastatic Uveal Melanoma (Dr. David Eschelman; 60 minutes)
• High-Risk Uveal Melanoma and Adjuvant Therapies (Dr. Jose Lutzky; 30 minutes)
• Current Status of Systemic Therapy for Uveal Melanoma (Dr. Ahmad Tarhini; 20 minutes)
• Current Clinical Trials for Metastatic Uveal Melanoma (Dr. Nikhil Khushalani; 25 minutes)
• Q&A About Systemic Treatment & Metastatic Disease (Panel of Presenters; 20 minutes)
Primary and Metastatic
• A Field of Hope: Ocular Melanoma Research Updates and Discussion (Keiran Smalley, PhD; Dr. Alison Skalet; Florian Karreth, PhD; and David Morse, PhD; 70 minutes)
All videotaped presentations from this conference
OM Diagnosis, Genetics, Treatment, and Research:
• KIMMTRAK Approved: Now What? (Dr. Meredith McKean and Dr. Justin Moser; 50 minutes)
• Ocular Melanoma Mets Explained (Dr. Meredith McKean, Dr. Justin Moser, and Dr. Maureen Sanger; 50 minutes)
• Standards of Care in Uveal Melanoma (Dr. Peter Hovland, Dr. David Reichstein, and Dr. Amy Schefler; 55 minutes)
• What Is the INSIGHT Ocular Melanoma Patient Registry? (Dr. Armin Afshar; 35 minutes)
• Your Eye After Plaque Brachytherapy Treatment (Dr. David Reichstein; 55 minutes)
Mental Health and Self-Advocacy:
Links to videotaped conference presentations on these two topics can be found on EyeMelanoma.org's Patient Empowerment webpage.
Low Vision:
Link to videotaped conference presentation on low-vision tools and techniques can be found on EyeMelanoma.org's Vision-Related Support webpage.
All videotaped presentations from this conference
Medical Presentations:
• Ocular Melanoma Eye Treatments, Side Effects, and How to Manage Them (Dr. Rumana Hussain; 35 minutes)
• Liver-Directed Therapies and How They Impact Quality of Life (Dr. Brian Stedman; 50 minutes)
• Uveal Melanoma UK Guidelines, Update on Systemic Treatments, and Update on Current Trials (Prof. Tobias Arkenau and Dr. Paul Nathan; 90 minutes)
All videotaped presentations from this conference
Video of Clinical Research Sessions: Part 1
• Primary Ocular Melanoma 101 (Dr. Carol Shield; 51:25 to 1:27:04)
• Post-Primary Treatment (Dr. Sara Lally; 1:27:04 to 1:51:21)
• Surveillance and Adjuvant Therapy (Dr. Rino Seedor; 1:51:21 to 2:10:00)
• Past, Present, and Future of Uveal Melanoma (Dr. Takami Sato; 2:49:00 to 3:19:40)
Video of Clinical Research Sessions: Part 2
• Treatments for Metastatic Disease: Liver Directed Therapies (Order of presenters: Dr. Rani Anne, Dr. Robert Adamo, and Dr. Carin Gonsalves; 0:00 to 1:08:07)
• Treatments for Metastatic Disease: Immunotherapies (Dr. Marlana Orloff; 1:08:07 to 1:34:52)
• Treatments for Metastatic Disease: Molecular Targeted Therapies (Dr. Rino Seedor; 1:34:52 to 1:51:57)
• Basic Science Updates (Dr. Andrew Aplin; 1:51:57 to 2:19:07)
• Closing Remarks (Dr. Sara Selig; 2:19:07 to 2:25:00)
• Current and Emerging Systemic Treatment Choices for Metastatic Uveal Melanoma (Dr. Paul Nathan; 30 minutes)
• Novel Treatments of Uveal Melanoma (Prof. Jonas Nilsson; 20 minutes)
• Liver-Directed Therapies for Metastatic Uveal Melanoma (Dr. David Eschelman; 20 minutes)
• Australian National Uveal Melanoma Treatment Pathway (Dr. John McKenzie; 20 minutes)
• Ocular Prostheses (Ocularist Camille Loyer; 15 minutes)
• A Global Survey on Ruthenium Eye Plaque Practice (Dr. Lotte Fog; 15 minutes)
• Another Option in the Radiotherapy Toolkit: Gantry-Based Proton Therapy (Dr. Amanda Deisher; 15 minutes)
• Proton Therapy for Uveal Melanoma (Dr. Sachin Salvi; 20 minutes)
• Pathology of Uveal Melanoma (Prof. Penny McKelvie; 20 minutes)
• Transretinal Tumour Biopsy Techniques (Prof. Heinrich Heimann; 15 minutes)
• Uveal Melanoma Biopsy at the Time of Plaque Brachytherapy (Dr. Rod O'Day; 15 minutes)
• Genetics and Genomics in Uveal Melanoma (Dr. Peter Johansson; 15 minutes)
• Proteomics in Uveal Melanoma (Prof. Sarah Coupland; 15 minutes)
• Liquid Biopsies in Uveal Melanoma (Dr. Aaron Beasley; 15 minutes)
OM Diagnosis, Genetics, Treatment, and Research:
• Ocular Melanoma Advocacy (Melanoma Research Foundation's Cassie Beisel; 50 minutes)
• Ocular Melanoma Clinical Trials (Dr. Richard Carvajal, Dr. Marlana Orloff, Dr. Sapna Patel, and Dr. Sara Selig; 75 minutes)
• Upcoming Ocular Melanoma Treatments (Dr. Richard Carvajal and Dr. Sara Selig; 35 minutes)
• VISION Patient Registry Update (Dr. Richard Carvajal and Dr. Sara Selig; 60 minutes)
All videotaped presentations from this conference
OM Diagnosis, Genetics, Treatment, and Research:
• How My Patients Made Me a Better Ocular Oncologist (Dr. Bertil Damato; 45 minutes)
• Keynote Presentation: What's New in Uveal Melanoma in 2021 (Dr. Prithvi Mruthyunjaya; 45 minutes)
• Making Drug Development Work For Uncommon Cancers (Dr. Anthony Tolcher; 45 minutes)
• Navigating a Diagnosis of Metastatic Uveal Melanoma (Dr. Adil Daud and Dr. Justin Moser; 50 minutes)
• Treatment of Advanced Uveal Melanoma (Dr. Jose Lutzky; 45 minutes)
• Uveal Melanoma Genetics Explained (Genetic counselor Jaime Jessen and Dr. Basil Williams; 50 minutes)
• What to Expect After Radiation Treatment for Uveal Melanoma: A Patient's Perspective (Dr. Armin Afshar and Dr. Timothy Murray; 50 minutes)
• What's New in Uveal Melanoma — NCCN Guidelines' Prognostic Information and Standards of Care (Dr. David Reichstein, Dr. Amy Schefler, and Dr. Andrew Stacey; 50 minutes)
• Why Should I Join a Registry? About the INSIGHT Ocular Melanoma Patient Registry (Dr. Armin Afshar and Dr. Bertil Damato; 45 minutes)
Mental Health and Self-Advocacy:
Links to videotaped conference presentations on these two topics can be found on EyeMelanoma.org's Patient Empowerment webpage.
Low Vision:
Links to videotaped conference presentations on low-vision tools and techniques can be found on EyeMelanoma.org's Vision-Related Support webpage.
All videotaped presentations from this conference
IN ORDER TO HIGHLIGHT THE LATEST INFORMATION ON ALL TOPICS, ONLY OCULAR MELANOMA CONFERENCE PRESENTATIONS MADE DURING THE PAST TWO YEARS STAY LISTED ON THIS WEBPAGE EACH MONTH
New information added to this webpage: September 14, 2023
Links to all external sites re-verified on this webpage: September 6, 2023
Feedback? Email: Erica@EyeMelanoma.org
This not-for-profit website does not contain any advertisements and does not receive funding/donations of any kind.
Information on this site should not be used as a substitute for professional medical care.
Copyright © 2011–2023. EYEMELANOMA.ORG. All Rights Reserved.
EyeMelanoma.org has been providing current information on ocular melanoma since 2011.
This nonprofit website does not contain any advertisements and does not receive funding/donations of any kind.
Google Analytics is used within this site to determine the number of visitors. Data is anonymous.